相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Physical Activity and Better Medication Compliance Improve Mini-Mental State Examination Scores in the Elderly
Fabiana Costa Guimaraes et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2015)
Antihypertensive Therapy and Cerebral Hemodynamics in Executive Mild Cognitive Impairment: Results of a Pilot Randomized Clinical Trial
Ihab Hajar et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
Antihypertensive drugs decrease risk of Alzheimer disease Ginkgo Evaluation of Memory Study
Sevil Yasar et al.
NEUROLOGY (2013)
RAS Inhibition Attenuates Cognitive Impairment by Reducing Blood-Brain Barrier Permeability in Hypertensive Subjects
Nicolas Pelisch et al.
CURRENT HYPERTENSION REVIEWS (2013)
Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series
Ihab Hajjar et al.
ARCHIVES OF NEUROLOGY (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
The Alzheimer's Disease Centers' Uniform Data Set (UDS) The Neuropsychologic Test Battery
Sandra Weintraub et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With Hypertension Results From the Cardiovascular Health Study
Kaycee M. Sink et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia Two Roads Converged
Suzanne Craft
ARCHIVES OF NEUROLOGY (2009)
Treatment of vascular risk factors is associated with slower decline in Alzheimer disease
Yan Deschaintre et al.
NEUROLOGY (2009)
Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy
J. S. Miners et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2008)
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
Jun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan
T Ohrui et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study
G Onder et al.
LANCET (2002)
Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia
E Savaskan et al.
NEUROBIOLOGY OF AGING (2001)
Midlife vascular risk factors and late-life mild cognitive impairment -: A population-based study
M Kivipelto et al.
NEUROLOGY (2001)